Oncolytics BiotechONCY
13F holders, Q2 2026 (June 30)1holders −56
1new positions
6sold out
$0.95avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings, down 56 from Q1 2026. 1 opened new positions and 6 sold out. The largest holder was Y-Intercept (Hong Kong) Ltd ($13K).
- Company
- Oncolytics Biotech Inc.
- CUSIP
- 682310875
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $13K |
| Exits | 6 | $142K |
All 13F filers, Q1 2026 → Q2 2026: 13,290 shares bought and 158,967 shares sold, net −145,677 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 13,290 | $13K |
"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.